Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ligence Heart

K-Number: K252105 · 2025-09-26

ApplicantLigence Uab
Decision Date2025-09-26
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Ligence Heart is a medical device manufactured by Ligence Uab. It received FDA 510(k) clearance on 2025-09-26 under approval number K252105. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ligence Heart?

Ligence Heart is a medical device that received FDA 510(k) clearance on 2025-09-26. It is manufactured by Ligence Uab. The 510(k) number is K252105.

When was Ligence Heart approved by the FDA?

Ligence Heart received FDA 510(k) clearance on 2025-09-26, under approval number K252105.

What company makes Ligence Heart?

Ligence Heart is manufactured by Ligence Uab.

What is the FDA product code for Ligence Heart?

The FDA product code for Ligence Heart is QIH.

Other Devices by Ligence Uab

K253535Ligence Heart

Related Devices (Code: QIH)

K191647QLAB Advanced Quantification SoftwarePhilips Health Care K191171EchoGo CoreUltromics, Ltd. K201195syngo.via MI Workflows, syngo MBFSiemens Medical Solutions USA, Inc. K202013WRDensity by Whiterabbit.aiWhiterabbit.Ai, Inc. K202546LVivo SeamlessDia Imaging Analysis, Ltd. K193283AI-Rad Companion Prostate MRSiemens Medical Solutions USA, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑